¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѳ»ºÐºñÇÐȸ (¿Â¶óÀÎ) 2021³â Postgraduate Course : 2021-09-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѳ»ºÐºñÇÐȸ (¿Â¶óÀÎ) 2021³â Postgraduate Course : 2021-09-25
±³À°ÀÏÀÚ : 2021-09-25
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021³â Postgraduate Course
ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
´ã´çÀÚ : È«Áö¼ö
¿¬¶ôó : 02-2038-3771  
À̸ÞÀÏ : endo@endocrinology.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 70,000¿ø      
ºñ°í ºÀÁ÷ÀÇ/°³¿øÀÇ 5¸¸¿ø (ºñȸ¿ø 7¸¸¿ø)Àü°øÀÇ ¹× ±âŸ(±âÃÊÀÇÇÐÀÚ/°£È£»ç/¾à»ç µî) 3¸¸¿ø(ºñȸ¿ø 5¸¸¿ø)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-25  09:00~09:25 Áú·®ºÐ¼®¹ý ±âÃÊ À̷Р ¿ÀÇѺó(¼­°­´ë) 
±³À°½Ã°£ 09-25  09:25~09:50 ÀÓ»ó½Ã·á ¹Ì·®ºÐ¼®À» À§ÇÑ ½Ã·á °ü¸®  ÇÑ»ó¹ü(Áß¾Ó´ë) 
±³À°½Ã°£ 09-25  09:50~10:15 ÀÓ»ó½Ã·á ³» steroidogenesis Æò°¡ ±â¼ú  ÃÖ¸¸È£(KIST) 
±³À°½Ã°£ 09-25  10:15~10:40 ÀÓ»ó°Ë»ç½Ç¿¡¼­ÀÇ Áú·®ºÐ¼®¹ý µµÀÔ°ú ¿î¿µ  ¹ÚÇüµÎ(¼º±Õ°üÀÇ´ë) 
È޽Ġ09-25  10:40~10:50 Break  () 
±³À°½Ã°£ 09-25  10:50~11:15 Approach to the patient with an adrenal incidentaloma  ±èÈ¿Á¤(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 09-25  11:15~11:40 New drugs for pitutiary diseases  ±¸Ã¶·æ(¿¬¼¼ÀÇ´ë) 
Åä·Ð 09-25  11:40~12:05 Q&A ¹× Panel Discussion  () 
½Ä»ç 09-25  12:05~12:45 Lunch Break  () 
±³À°½Ã°£ 09-25  12:45~13:10 Future game changer in diabetes (weekly basal insulin (icodec) and imeglimin)  È«ÁØÈ­(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 09-25  13:10~13:35 SGLT2 inhibitor in chronic kidney disease, where is the lowest limit of eGFR?  ±è½Å°ï(°í·ÁÀÇ´ë) 
Åä·Ð 09-25  13:35~14:00 Q&A ¹× Panel Discussion  () 
È޽Ġ09-25  14:00~14:10 Break  () 
±³À°½Ã°£ 09-25  14:10~14:35 Best treatment option for RAI-refractory advanced thyroid cancer  Àü¹ÎÁö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-25  14:35~15:00 How to adopt the molecular testing in thyroid nodule diagnosis  Á¶¼±¿í(¼­¿ïÀÇ´ë) 
Åä·Ð 09-25  15:00~15:25 Q&A ¹× Panel Discussion  () 
È޽Ġ09-25  15:25~15:35 Break  () 
±³À°½Ã°£ 09-25  15:35~16:00 Mechanisms and therapeutic effects of osteoporosis medications  ¹é±âÇö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-25  16:00~16:25 Management strategies after discontinuation of denosumab  ±èºÎ°æ(°í½ÅÀÇ´ë) 
Åä·Ð 09-25  16:25~16:50 Q&A ¹× Panel Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѳ»ºÐºñÇÐȸ (¿Â¶óÀÎ) 2021³â Postgraduate Course : 2021-09-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÇѾç´ëÇб³º´¿ø (¿Â¶óÀÎ) APTS(Asia-Pacific Society of Thyroid Surgery) : 2021-09-25
´ÙÀ½±Û °­³²¼¼ºê¶õ½ºº´¿ø Á¦ 14ȸ Èñ±Í½Å°æ±ÙÀ°°èÁúȯ¡¤È£ÈíÀçÈ° ½ÉÆ÷Áö¾ö : 2021-09-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
105 °æ³² ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ 2018 Post Graduate Asthma School (1ÀÏÂ÷) : 2018-08-25 0 412 2018-07-28
104 ÀÎõ Á¦8Â÷ °¡Å縯´ëÇб³ ÀÎõ¼º¸ðº´¿ø È£Èí±â³»°ú ±â°èȯ±â ¿öÅ©¼ó : 2018-08-25 0 1,258 2018-07-28
103 ¼­¿ï ´ëÇѼҾƽŰæÇÐȸ Fellowship in Training : 2018-08-25 0 533 2018-07-28
102 °æ±â Á¦5Â÷ ¾Æ½Ã¾ÆºÎÀÎÁ¾¾çÇÐȸ ¿öÅ©¼ó(ASGO 5th International Workshop on Gynecologic Oncology in conjunction with 12th KSGO Workshop for Young Gynecologic Oncologists) : 2018-08-25 0 329 2018-07-28
101 ¼­¿ï 2018³â ´ëÇѺÎÀ§¸¶ÃëÇÐȸ Á¦2ȸ Çмú´ëȸ : 2018-08-25 0 468 2018-07-28
100 ÀüºÏ Á¦ 67ȸ Çѳ² ÇǺΰúÇÐȸ Çмú´ëȸ : 2018-08-25 0 1,070 2018-07-28
99 °æºÏ Ä¥°î°æºÏ´ëÇб³º´¿ø °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ¸¶ÃëÅëÁõÀÇÇаú ÇÏ°è ½ÉÆ÷Áö¾ö : 2018-08-25 0 629 2018-07-28
98 °æ±â ´ëÇѽŰæ±Ù°ñ°ÝÃÊÀ½ÆÄÇÐȸ Á¦3ȸ ÇÚÁî¿Â ¿öÅ©¼ó Á¦1ºÎ : 2018-08-25 0 365 2018-07-28
97 °æ±â ´ëÇѽŰæ±Ù°ñ°ÝÃÊÀ½ÆÄÇÐȸ Á¦3ȸ ÇÚÁî¿Â ¿öÅ©¼ó Á¦2ºÎ : 2018-08-25 0 878 2018-07-28
96 ´ëÀü 2018³â ´ëÇÑÅëÁõÇÐȸ Áö¹æ¼øȸ ÃÊÀ½ÆÄ ¹× °æ¸·¿Ü³»½Ã°æWorkshop_Live Surgery with Epiduroscopy : 2018-08-24 0 331 2018-07-28
95 ÀÎõ 2018³â ´ëÇѺҾÈÀÇÇÐȸ Çϰ迬¼ö±³À° : 2018-08-24 0 311 2018-07-28
94 ÃæºÏ ±¹¸³ÀÇ·á¿ø ÃÊÀ½ÆÄ À¯µµÇÏ ½Ã¼ú ¹× ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ ¿ª·® °­È­ : 2018-08-24 0 357 2018-07-28
93 ºÎ»ê ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ Summer Intensive Course 2018 of KSIN : 2018-08-24 0 387 2018-07-28
92 ¼­¿ï 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ±³À°[»çÀüµî·Ï Çʼö] : 2018-08-24 0 305 2018-07-28
91 ¼­¿ï 2018³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ(8/24) : 2018-08-24 0 322 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷